TY - JOUR
T1 - Development of the nih patient-reported outcomes measurement information system (Promis) medication adherence scale (pmas)
AU - Peipert, John Devin
AU - Badawy, Sherif M.
AU - Baik, Sharon H.
AU - Oswald, Laura B.
AU - Efficace, Fabio
AU - Garcia, Sofia F.
AU - Mroczek, Daniel K.
AU - Wolf, Michael
AU - Kaiser, Karen
AU - Yanez, Betina
AU - Cella, David
N1 - Funding Information:
Dr John Devin Peipert reports grants from Pfizer, Bristol Myers Squibb, and Veloxis Pharmaceuticals and personal fees from AstraZeneca, outside the submitted work. Dr Fabio Efficace reports personal fees from Amgen, Bristol Myers Squibb, Orsenix, Incyte, Takeda, grants from Amgen, outside the submitted work. Dr Daniel K Mroczek reports personal fees from International Drug Development Institute, outside the submitted work. Dr Michael Wolf reports grants from Amgen, grants, personal fees from Merck, Sharpe & Dohme, Pfizer, personal fees from Sanofi, Luto UK, grants from Eli Lilly, outside the submitted work. Dr David Cella reports grants from the National Institutes of Health, during the conduct of the study. Dr Laura B Oswald is now affiliated with Health Outcomes and Behavior Program, Moffitt Cancer Center. The authors report no other conflicts of interest in this work.
Publisher Copyright:
© 2020 Peipert et al.
PY - 2020
Y1 - 2020
N2 - Poor medication adherence is associated with reduced drug effectiveness, poor health-related quality of life, increased morbidity and mortality, and increased healthcare utilization and cost. Including the patient’s voice is essential in understanding barriers to adherence. Useful patient-reported adherence measures are brief, inexpensive, non-invasive; can indicate barriers to adherence; and can be incorporated in electronic health records. The NIH Patient-Reported Outcomes Measurement Information System (PROMIS® ) includes high-quality, freely available patient-reported measures covering many important constructs in patient-centered research but does not include a medication adherence measure. To fill this gap, we developed the PROMIS Medication Adherence Scale (PMAS) using the rigorous PROMIS instrument development guidelines. To develop the PMAS, we first conducted a review of the reviews, which enabled us to identify content areas relevant to medication adherence behavior. Then, we conducted qualitative research to elicit patients’ views of and experiences with medication adherence. This process identified the following important content areas to guide item writing: extent medication is taken, knowledge of medication regimen, beliefs about medication, remembering to take medica-tion, skipping due to side effects, skipping due to feeling better, and cost of medications. Based on the results of these activities, we wrote items and aimed to retain 1–2 items per content area. The final item set included 9 total adherence items, which were then refined through intensive comprehension and translatability review, as well as cognitive interviews. Future steps include testing the PMAS’s validity.
AB - Poor medication adherence is associated with reduced drug effectiveness, poor health-related quality of life, increased morbidity and mortality, and increased healthcare utilization and cost. Including the patient’s voice is essential in understanding barriers to adherence. Useful patient-reported adherence measures are brief, inexpensive, non-invasive; can indicate barriers to adherence; and can be incorporated in electronic health records. The NIH Patient-Reported Outcomes Measurement Information System (PROMIS® ) includes high-quality, freely available patient-reported measures covering many important constructs in patient-centered research but does not include a medication adherence measure. To fill this gap, we developed the PROMIS Medication Adherence Scale (PMAS) using the rigorous PROMIS instrument development guidelines. To develop the PMAS, we first conducted a review of the reviews, which enabled us to identify content areas relevant to medication adherence behavior. Then, we conducted qualitative research to elicit patients’ views of and experiences with medication adherence. This process identified the following important content areas to guide item writing: extent medication is taken, knowledge of medication regimen, beliefs about medication, remembering to take medica-tion, skipping due to side effects, skipping due to feeling better, and cost of medications. Based on the results of these activities, we wrote items and aimed to retain 1–2 items per content area. The final item set included 9 total adherence items, which were then refined through intensive comprehension and translatability review, as well as cognitive interviews. Future steps include testing the PMAS’s validity.
KW - Medication adherence
KW - PROMIS
KW - Patient-reported outcome
UR - http://www.scopus.com/inward/record.url?scp=85086277125&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086277125&partnerID=8YFLogxK
U2 - 10.2147/PPA.S249079
DO - 10.2147/PPA.S249079
M3 - Article
C2 - 32606615
AN - SCOPUS:85086277125
SN - 1177-889X
VL - 14
SP - 971
EP - 983
JO - Patient Preference and Adherence
JF - Patient Preference and Adherence
ER -